chr2-77518656-A-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001134745.3(LRRTM4):c.1213T>A(p.Ser405Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000075 in 1,613,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001134745.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRTM4 | NM_001134745.3 | c.1213T>A | p.Ser405Thr | missense_variant | 3/4 | ENST00000409884.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRTM4 | ENST00000409884.6 | c.1213T>A | p.Ser405Thr | missense_variant | 3/4 | 1 | NM_001134745.3 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000790 AC: 12AN: 151968Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000153 AC: 38AN: 248708Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134936
GnomAD4 exome AF: 0.0000746 AC: 109AN: 1461334Hom.: 0 Cov.: 34 AF XY: 0.0000674 AC XY: 49AN XY: 726956
GnomAD4 genome AF: 0.0000790 AC: 12AN: 151968Hom.: 0 Cov.: 32 AF XY: 0.0000674 AC XY: 5AN XY: 74200
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2023 | The c.1213T>A (p.S405T) alteration is located in exon 3 (coding exon 2) of the LRRTM4 gene. This alteration results from a T to A substitution at nucleotide position 1213, causing the serine (S) at amino acid position 405 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at